Literature DB >> 23010807

Applying competing risks regression models: an overview.

Bernhard Haller1, Georg Schmidt, Kurt Ulm.   

Abstract

In many clinical research applications the time to occurrence of one event of interest, that may be obscured by another--so called competing--event, is investigated. Specific interventions can only have an effect on the endpoint they address or research questions might focus on risk factors for a certain outcome. Different approaches for the analysis of time-to-event data in the presence of competing risks were introduced in the last decades including some new methodologies, which are not yet frequently used in the analysis of competing risks data. Cause-specific hazard regression, subdistribution hazard regression, mixture models, vertical modelling and the analysis of time-to-event data based on pseudo-observations are described in this article and are applied to a dataset of a cohort study intended to establish risk stratification for cardiac death after myocardial infarction. Data analysts are encouraged to use the appropriate methods for their specific research questions by comparing different regression approaches in the competing risks setting regarding assumptions, methodology and interpretation of the results. Notes on application of the mentioned methods using the statistical software R are presented and extensions to the presented standard methods proposed in statistical literature are mentioned.

Entities:  

Mesh:

Year:  2012        PMID: 23010807     DOI: 10.1007/s10985-012-9230-8

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  32 in total

1.  Interpretability and importance of functionals in competing risks and multistate models.

Authors:  Per Kragh Andersen; Niels Keiding
Journal:  Stat Med       Date:  2011-11-14       Impact factor: 2.373

2.  Misspecified regression model for the subdistribution hazard of a competing risk.

Authors:  A Latouche; V Boisson; S Chevret; R Porcher
Journal:  Stat Med       Date:  2007-02-28       Impact factor: 2.373

3.  A competing risks analysis of bloodstream infection after stem-cell transplantation using subdistribution hazards and cause-specific hazards.

Authors:  Jan Beyersmann; Markus Dettenkofer; Hartmut Bertz; Martin Schumacher
Journal:  Stat Med       Date:  2007-12-30       Impact factor: 2.373

Review 4.  Pseudo-observations in survival analysis.

Authors:  Per Kragh Andersen; Maja Pohar Perme
Journal:  Stat Methods Med Res       Date:  2009-08-04       Impact factor: 3.021

5.  A note on quantifying follow-up in studies of failure time.

Authors:  M Schemper; T L Smith
Journal:  Control Clin Trials       Date:  1996-08

6.  The analysis of failure times in the presence of competing risks.

Authors:  R L Prentice; J D Kalbfleisch; A V Peterson; N Flournoy; V T Farewell; N E Breslow
Journal:  Biometrics       Date:  1978-12       Impact factor: 2.571

7.  Risk stratification after acute myocardial infarction by heart rate turbulence.

Authors:  Petra Barthel; Raphael Schneider; Axel Bauer; Kurt Ulm; Claus Schmitt; Albert Schömig; Georg Schmidt
Journal:  Circulation       Date:  2003-08-25       Impact factor: 29.690

8.  Competing risk regression models for epidemiologic data.

Authors:  Bryan Lau; Stephen R Cole; Stephen J Gange
Journal:  Am J Epidemiol       Date:  2009-06-03       Impact factor: 4.897

9.  Analysis and design of randomised clinical trials involving competing risks endpoints.

Authors:  Bee-Choo Tai; Joseph Wee; David Machin
Journal:  Trials       Date:  2011-05-19       Impact factor: 2.279

10.  Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk).

Authors:  Axel Bauer; Petra Barthel; Raphael Schneider; Kurt Ulm; Alexander Müller; Anke Joeinig; Raphael Stich; Antti Kiviniemi; Katerina Hnatkova; Heikki Huikuri; Albert Schömig; Marek Malik; Georg Schmidt
Journal:  Eur Heart J       Date:  2008-12-23       Impact factor: 29.983

View more
  33 in total

1.  Natural history of diseases: Statistical designs and issues.

Authors:  Nicholas P Jewell
Journal:  Clin Pharmacol Ther       Date:  2016-08-18       Impact factor: 6.875

2.  An introduction to survival models: in honor of Ross Prentice.

Authors:  David Oakes
Journal:  Lifetime Data Anal       Date:  2013-07-06       Impact factor: 1.588

3.  Survival analysis in the presence of competing risks.

Authors:  Zhongheng Zhang
Journal:  Ann Transl Med       Date:  2017-02

4.  Time-varying survival effects for squamous cell carcinomas at oropharyngeal and nonoropharyngeal head and neck sites in the United States, 1973-2015.

Authors:  Andrew F Brouwer; Kevin He; Steven B Chinn; Alison M Mondul; Christina H Chapman; Marc D Ryser; Mousumi Banerjee; Marisa C Eisenberg; Rafael Meza; Jeremy M G Taylor
Journal:  Cancer       Date:  2020-09-05       Impact factor: 6.860

5.  Survival Without Cardiac Transplantation Among Children With Dilated Cardiomyopathy.

Authors:  Rakesh K Singh; Charles E Canter; Ling Shi; Steven D Colan; Debra A Dodd; Melanie D Everitt; Daphne T Hsu; John L Jefferies; Paul F Kantor; Elfriede Pahl; Joseph W Rossano; Jeffrey A Towbin; James D Wilkinson; Steven E Lipshultz
Journal:  J Am Coll Cardiol       Date:  2017-11-28       Impact factor: 24.094

6.  Joint Inference for Competing Risks Survival Data.

Authors:  Gang Li; Qing Yang
Journal:  J Am Stat Assoc       Date:  2016-10-18       Impact factor: 5.033

7.  Prognostic factors in Asian and white American patients with cervical cancer, considering competing risks.

Authors:  Y Hou; S Guo; J Lyu; Z Lu; Z Yang; D Liu; Z Chen
Journal:  Curr Oncol       Date:  2019-06-01       Impact factor: 3.677

8.  Cardiovascular disease among people with drug use disorders.

Authors:  Birgitte Thylstrup; Thomas Clausen; Morten Hesse
Journal:  Int J Public Health       Date:  2015-06-24       Impact factor: 3.380

9.  Development and validation of a competing risk model for second primary pancreatic ductal adenocarcinoma: A population-based study.

Authors:  Lishan Song; Chaojie Xu; Tong Zhang; Shengyang Chen; Zhigang Shi; Shuiquan Hu; Bingbing Cheng; Hao Tong; Guangkun Wei; Xiaoyong Li
Journal:  Front Surg       Date:  2022-08-30

10.  Survival, Healthcare Utilization, and End-of-life Care Among Older Adults With Malignancy-associated Bowel Obstruction: Comparative Study of Surgery, Venting Gastrostomy, or Medical Management.

Authors:  Elizabeth J Lilley; John W Scott; Joel E Goldberg; Christy E Cauley; Jennifer S Temel; Andrew S Epstein; Stuart R Lipsitz; Brittany L Smalls; Adil H Haider; Angela M Bader; Joel S Weissman; Zara Cooper
Journal:  Ann Surg       Date:  2018-04       Impact factor: 13.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.